High-dose medroxyprogesterone acetate (MPA) in advanced chemotherapy-resistant ovarian carcinoma: a phase II study.

Kristian Aabo, Pedersen Ag, I Haid, P Dombernowsky

PubMed · 1982 · 24 citations · 0 references

Concepts